Lehman CE - Search Results

1

The role of fragile sites in sporadic papillary thyroid carcinoma.

Dillon LW, Lehman CE, Wang YH. Dillon LW, et al. Among authors: lehman ce. J Thyroid Res. 2012;2012:927683. doi: 10.1155/2012/927683. Epub 2012 Jun 11. J Thyroid Res. 2012. PMID: 22762011 Free PMC article.

2

DNA topoisomerases participate in fragility of the oncogene RET.

Dillon LW, Pierce LC, Lehman CE, Nikiforov YE, Wang YH. Dillon LW, et al. Among authors: lehman ce. PLoS One. 2013 Sep 11;8(9):e75741. doi: 10.1371/journal.pone.0075741. eCollection 2013. PLoS One. 2013. PMID: 24040417 Free PMC article.

3

DNA secondary structure at chromosomal fragile sites in human disease.

Thys RG, Lehman CE, Pierce LC, Wang YH. Thys RG, et al. Among authors: lehman ce. Curr Genomics. 2015 Feb;16(1):60-70. doi: 10.2174/1389202916666150114223205. Curr Genomics. 2015. PMID: 25937814 Free PMC article.

4

Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells.

Thys RG, Lehman CE, Pierce LC, Wang YH. Thys RG, et al. Among authors: lehman ce. Mutat Res. 2015 Sep;779:86-95. doi: 10.1016/j.mrfmmm.2015.06.011. Epub 2015 Jun 27. Mutat Res. 2015. PMID: 26163765 Free PMC article.

5

DNA fragile site breakage as a measure of chemical exposure and predictor of individual susceptibility to form oncogenic rearrangements.

Lehman CE, Dillon LW, Nikiforov YE, Wang YH. Lehman CE, et al. Carcinogenesis. 2017 Mar 1;38(3):293-301. doi: 10.1093/carcin/bgw210. Carcinogenesis. 2017. PMID: 28069693 Free PMC article.

6

The Impact of dUTPase on Ribonucleotide Reductase-Induced Genome Instability in Cancer Cells.

Chen CW, Tsao N, Huang LY, Yen Y, Liu X, Lehman C, Wang YH, Tseng MC, Chen YJ, Ho YC, Chen CF, Chang ZF. Chen CW, et al. Cell Rep. 2016 Aug 2;16(5):1287-1299. doi: 10.1016/j.celrep.2016.06.094. Epub 2016 Jul 21. Cell Rep. 2016. PMID: 27452458 Free article.

7

IGF1R and Src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK.

Lehman CE, Spencer A, Hall S, Shaw JJP, Wulfkuhle J, Petricoin EF, Bekiranov S, Jameson MJ, Gioeli D. Lehman CE, et al. Sci Rep. 2021 May 24;11(1):10826. doi: 10.1038/s41598-021-90289-1. Sci Rep. 2021. PMID: 34031486 Free PMC article.

8

Antitumor effect of insulin-like growth factor-1 receptor inhibition in head and neck squamous cell carcinoma.

Lehman CE, Khalil AA, Axelrod MJ, Dougherty MI, Schoeff SS, Taniguchi LE, Mendez RE, David AP, McGarey PO Jr,, Hubbard MA, Donaldson L, Frierson HF Jr,, Stelow EB, Bekiranov S, Wulfkuhle JD, Petricoin EF, Gioeli DG, Jameson MJ. Lehman CE, et al. Laryngoscope. 2020 Jun;130(6):1470-1478. doi: 10.1002/lary.28236. Epub 2019 Aug 21. Laryngoscope. 2020. PMID: 31433065

9

PRAS40 Phosphorylation Correlates with Insulin-Like Growth Factor-1 Receptor-Induced Resistance to Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells.

Dougherty MI, Lehman CE, Spencer A, Mendez RE, David AP, Taniguchi LE, Wulfkuhle J, Petricoin EF, Gioeli D, Jameson MJ. Dougherty MI, et al. Among authors: lehman ce. Mol Cancer Res. 2020 Sep;18(9):1392-1401. doi: 10.1158/1541-7786.MCR-19-0592. Epub 2020 May 28. Mol Cancer Res. 2020. PMID: 32467173 Free PMC article.

10

Survivin in Insulin-Like Growth Factor-Induced Resistance to Lapatinib in Head and Neck Squamous Carcinoma Cells.

Lehman CE, Mendez RE, Dougherty MI, Allak A, Adejumo OL, Taniguchi LE, Khalil A, Gioeli DG, Jameson MJ. Lehman CE, et al. Front Oncol. 2019 Jan 23;9:13. doi: 10.3389/fonc.2019.00013. eCollection 2019. Front Oncol. 2019. PMID: 30729097 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters